Advertising Disclaimer
Published online December 1, 2005
PEDIATRICS Vol. 116 No. 6 December 2005, pp. e868-e873 (doi:10.1542/peds.2005-1301)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by King, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by King, J. C., Jr
Related Collections
Right arrow Infectious Disease & Immunity
Right arrowRelated AAP Red Book topics:
Influenza
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

ELECTRONIC ARTICLE

A Pilot Study of the Effectiveness of a School-Based Influenza Vaccination Program

James C. King, Jr, MD*, Ginny E. Cummings, CPNP*, Jeffrey Stoddard, MD{ddagger}, Bernard X. Readmond, RN*, Laurence S. Magder, PhD§, Mary Stong, EdD||, Margaret Hoffmaster, RN||, Judith Rubin, MD§, Theodore Tsai, MD, Elizabeth Ruff, MD# for the SchoolMist Study Group

* Pediatrics
§ Epidemiology, University of Maryland School of Medicine, Baltimore, Maryland
{ddagger} MedImmune, Inc, Gaithersburg, Maryland
|| Carroll County Public School System, Westminster, Maryland
Wyeth Vaccines, Philadelphia, Pennsylvania
# Carroll County Health Department, Westminster, Maryland

Objective. The objective of this study was to evaluate the feasibility of a school-based influenza immunization program.

Methods. Pupils and their families from 3 demographically similar elementary schools participated in this pilot, unblinded, controlled intervention study. Live attenuated influenza vaccine (FluMist) was made available to all eligible pupils in 1 target school during regular school hours. Two schools where vaccine was not offered served as control schools. All families from the 3 study schools were sent an anonymous questionnaire requesting 7-day recall data on fever or respiratory illness (FRI)-related medical visits, medications purchased, and days of school or paid work lost during the peak influenza week. Changes in weekly pupil absenteeism were also examined.

Results. One hundred eighty-five (40%) of the target school pupils received vaccine, of whom >50% were vaccinated ≤3 weeks before the influenza outbreak period. Questionnaires were returned by 43% to 51% of households. Significant (45–70%) relative reductions in FRI-related outcomes, including doctor visits by adults or children, prescription or other medicines purchased, and family schooldays or workdays missed, were observed for target school households, compared with control school households. The increases in absenteeism rates during the influenza outbreak period, compared with baseline rates earlier in the fall, were not significantly different between target and control schools. Within the target school, however, the increase in absenteeism rates was significantly smaller for the FluMist-vaccinated pupils, compared with the non–FluMist-vaccinated pupils.

Conclusions. This school-based influenza immunization program was associated with significant reductions in FRI-related outcomes in households of pupils attending an intervention school. These results might have underestimated the potential impact of FluMist, because the majority of children received intraepidemic vaccination.


Key Words: influenza • vaccination • live attenuated • school-based

Abbreviations: FRI, fever or respiratory illness • TIV, trivalent inactivated vaccine


Accepted Aug 10, 2005.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Arch Pediatr Adolesc MedHome page
C. M. Rand, P. G. Szilagyi, B.-K. Yoo, P. Auinger, C. Albertin, and M. S. Coleman
Additional Visit Burden for Universal Influenza Vaccination of US School-Aged Children and Adolescents
Arch Pediatr Adolesc Med, November 1, 2008; 162(11): 1048 - 1055.
[Abstract] [Full Text] [PDF]


Home page
Health Aff (Millwood)Home page
J. Schmier, S. Li, J. C. King Jr., K. Nichol, and P. J. Mahadevia
Benefits And Costs Of Immunizing Children Against Influenza At School: An Economic Analysis Based On A Large-Cluster Controlled Clinical Trial
Health Aff., March 1, 2008; 27(2): w96 - w104.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
J. C. King Jr., J. J. Stoddard, M. J. Gaglani, K. A. Moore, L. Magder, E. McClure, J. D. Rubin, J. A. Englund, and K. Neuzil
Effectiveness of School-Based Influenza Vaccination
N. Engl. J. Med., December 14, 2006; 355(24): 2523 - 2532.
[Abstract] [Full Text] [PDF]